Advancing ADC and Drug Product Solutions: CARBOGEN AMCIS Expertise Tuesday, 10 October 2023

Watch Episode 2 of our Customer Journey series on CARBOGEN AMCIS Drug Products, ADC & Bioconjugation services!

Bioconjugation & Antibody Drug Conjugates Friday, 31 March 2023

Brochure

Learn more about our Bioconjugation & Antibody Drug Conjugates services at CARBOGEN AMCIS

Discovery & Development of a New ADC Thursday, 09 June 2022

CARBOGEN AMCIS & Heidelberg Pharma Formula for Successful Collaboration

During the BOS Basel 2022 Heidelberg Pharma and CARBOGEN AMCIS presented their collaboration and fully synthetic route for α-Amanitin.

Mastering the Supply Chain Wednesday, 02 June 2021

Discovering a new ADC

After intense research investigations Heidelberg Pharma found a unique access to a fully synthetic route for α-Amanitin. With CARBOGEN AMCIS, Heidelberg Pharma developed a scalable and economical route providing α-Amanitin now available for the development of new therapeutic ADC’s.